NDC 62135-441 – Benzonatate
Benzonatate 200 mg/1 · Capsule · Oral
Product NDC62135-441
Product details
- Brand name
- Benzonatate
- Generic name
- Benzonatate
- Labeler
- Chartwell RX, LLC
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA040682
- Marketed since
- May 1, 2018
- Listing expires
- December 31, 2026
- Pharmacologic class
- Non-narcotic Antitussive
Active ingredients
- Benzonatate 200 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 62135-441-31 | 300 CAPSULE in 1 BOTTLE (62135-441-31) | Jan 5, 2023 |
| 62135-441-60 | 60 CAPSULE in 1 BOTTLE (62135-441-60) | Jan 5, 2023 |
Other Benzonatate products
- 50090-6080 Benzonatate 200 mg/1 · Capsule · A-S Medication Solutions
- 50090-6294 Benzonatate 200 mg/1 · Capsule · A-S Medication Solutions
- 50090-6850 Benzonatate 100 mg/1 · Capsule · A-S Medication Solutions
- 50090-6387 Benzonatate 100 mg/1 · Capsule · A-S Medication Solutions
- 50090-4968 Benzonatate 100 mg/1 · Capsule · A-S Medication Solutions
- 50090-4969 Benzonatate 100 mg/1 · Capsule · A-S Medication Solutions
- 50090-5409 Benzonatate 100 mg/1 · Capsule · A-S Medication Solutions
- 50090-5986 Benzonatate 100 mg/1 · Capsule · A-S Medication Solutions
- 68084-214 Benzonatate 100 mg/1 · Capsule · American Health Packaging
- 87519-111 Benzonatate 150 mg/1 · Capsule · Anvi Pharmaceuticals Inc
- 71610-692 Benzonatate 100 mg/1 · Capsule · Aphena Pharma Solutions - Tennessee, LLC
- 67877-573 Benzonatate 100 mg/1 · Capsule · Ascend Laboratories, LLC